Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
101 EUR
0.6%
Market Closed
Updated:
Apr 30, 2024
Gerresheimer AG
Revenue
|
Gerresheimer AG
Revenue Peer Comparison
Comparables:
E
EVT
S
1SXP
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gerresheimer AG
XETRA:GXI
|
Revenue
€2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
E
|
Evotec SE
XETRA:EVT
|
Revenue
€820.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
17%
|
CAGR 10-Years
26%
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Revenue
€898.6m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Revenue?
Revenue
2B
EUR
2B
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Revenue amounts to 2B EUR.
What is Gerresheimer AG's Revenue growth rate?
Revenue CAGR 10Y
5%
5%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Gerresheimer AG have been 12% over the past three years , 8% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
